Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Laumas Sandeep Create: Alert

All | News | Filings
Date FiledTypeDescription
06/28/2023 4 Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $17.52, valued at $297.8k
01/20/2023 4/A Laumas Sandeep (CFO and CBO) has filed a Form 4 on Instil Bio, Inc.
Txns: Granted 234,000 options to buy @ $8.62, valued at $2M
01/20/2023 4 Laumas Sandeep (CFO and CBO) has filed a Form 4 on Instil Bio, Inc.
Txns: Granted 415,000 options to buy @ $0.634, valued at $263.1k
05/23/2022 4 Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $13.24, valued at $225.1k
03/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2022 3 Laumas Sandeep (10% Owner) has filed a Form 3 on Hillstream BioPharma Inc.
07/12/2021 3 Laumas Sandeep (Director) has filed a Form 3 on Unicycive Therapeutics, Inc.
06/15/2021 4 Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 14,500 options to buy @ $37.86, valued at $549k
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
07/08/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2020 4 Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $49.74, valued at $994.8k
05/04/2020 4 Laumas Sandeep (Director) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought 424 convertible preferred @ $0
Bought 424 options to buy @ $0
05/04/2020 4 Laumas Sandeep (Director) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Granted 389,294 options to buy @ $0.6, valued at $233.6k
08/27/2019 4 Laumas Sandeep (CEO, Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Granted 400,000 options to buy @ $0.89, valued at $356k
07/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2019 4 Laumas Sandeep (CEO, Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought 409 shares @ $1.21, valued at $494.9
Bought 591 shares @ $1.22, valued at $721
05/28/2019 4 Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 14,700 options to buy @ $10.04, valued at $147.6k
05/23/2019 4 Laumas Sandeep (CEO, Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought 5,000 shares @ $1.38, valued at $6.9k
12/03/2018 4 Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought 1,000 shares @ $2.64, valued at $2.6k
Bought 1,000 shares @ $2.62, valued at $2.6k
Bought 1,000 shares @ $2.63, valued at $2.6k
11/29/2018 4 Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought 1,000 shares @ $2.55, valued at $2.6k
Bought 2,000 shares @ $2.56, valued at $5.1k
09/10/2018 4 Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought 500 shares @ $6.1, valued at $3.1k
08/30/2018 4 Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought 500 shares @ $5.24, valued at $2.6k
08/30/2018 4/A Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought 250 shares @ $4.9, valued at $1.2k
08/28/2018 4 Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.
Txns: Bought shares @ $4.9, valued at $0
Bought 250 shares @ $4.88, valued at $1.2k
Bought 95 shares @ $5.07, valued at $481.7
Bought 405 shares @ $5.08, valued at $2.1k
03/13/2018 4 Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 37,209 options @ $11, valued at $409.3k
03/07/2018 3 Laumas Sandeep (Director) has filed a Form 3 on BioXcel Therapeutics, Inc.
02/08/2018 3 Laumas Sandeep (Executive Chairman) has filed a Form 3 on INNOVATE BIOPHARMACEUTICALS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy